# Genotropin Treatment In Very Young Children Born Small For Gestational Age

> **NCT00627523** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 43 (actual)

## Conditions studied

- Infant, Small for Gestational Age

## Interventions

- **DRUG:** Genotropin (PN-180,307) Somatropin
- **DRUG:** Control-no treatment

## Key facts

- **NCT ID:** NCT00627523
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2014-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00627523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00627523, "Genotropin Treatment In Very Young Children Born Small For Gestational Age". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00627523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*